tiprankstipranks
Advertisement
Advertisement

HK:1011 Stock Latest News

China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
Company AnnouncementsChina NT Pharma Discloses Governance Dispute Behind Director’s Resignation
2d ago
1011
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
PremiumCompany Announcements
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
7d ago
1011
China NT Pharma details board and committee structure
PremiumCompany Announcements
China NT Pharma details board and committee structure
10d ago
1011
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
PremiumCompany Announcements
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
14d ago
1011
China NT Pharma Reshapes Audit Oversight with New Independent Director
PremiumCompany Announcements
China NT Pharma Reshapes Audit Oversight with New Independent Director
14d ago
1011
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
PremiumCompany AnnouncementsChina NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
22d ago
1011
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
Premium
Company Announcements
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
22d ago
1011
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
Premium
Company Announcements
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
1M ago
1011
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
PremiumCompany Announcements
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
2M ago
1011
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
PremiumCompany Announcements
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
2M ago
1011
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
PremiumCompany Announcements
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
2M ago
1011
China NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
China NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
2M ago
1011
China NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
PremiumCompany AnnouncementsChina NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
3M ago
1011
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
Premium
Company Announcements
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
3M ago
1011
China NT Pharma Halts Trading Pending Details on Convertible Bond Issue
Premium
Company Announcements
China NT Pharma Halts Trading Pending Details on Convertible Bond Issue
3M ago
1011
China NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
PremiumCompany Announcements
China NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
3M ago
1011
China NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
PremiumCompany Announcements
China NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
4M ago
1011
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
PremiumCompany Announcements
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
4M ago
1011
China NT Pharma Calls EGM to Approve Major Acquisition and Share Issuance
PremiumCompany Announcements
China NT Pharma Calls EGM to Approve Major Acquisition and Share Issuance
5M ago
1011
China NT Pharma Revises Terms of Medical Device Acquisition and Extends Long Stop Date
PremiumCompany AnnouncementsChina NT Pharma Revises Terms of Medical Device Acquisition and Extends Long Stop Date
5M ago
1011
China NT Pharma Group Announces Key Corporate Governance Appointments
Premium
Company Announcements
China NT Pharma Group Announces Key Corporate Governance Appointments
6M ago
1011
China NT Pharma Group Embraces AI for Orthopedic Market Transformation
Premium
Company Announcements
China NT Pharma Group Embraces AI for Orthopedic Market Transformation
6M ago
1011

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >